INCY | Incyte

70.40 -2.38 (-3.27%)

INCY Price Profile

Open

$71.63

CLOSE

$70.40

DAY RANGE

70.34 - 72.02

52 WEEK RANGE

61.91 - 88.26

MARKET CAP

16.24B

Trading volume

1.34M

Prev. Close

72.78

50 Day MA

70.36

Shares Outstanding

220.89M

Public Float

185.6M

Average Volume

2.02M

Beta

0.73

PEG Ratio

1.42

Shares Shorted

3.06M

% OF SHARES SHORTED

1.97%

Short Ratio

1.11

1 Year Performance

-20.27%

Diluted EPS (TTM)

2.41

Q Revenue Growth

0.31

Ebitda

713.3M

Gross Profit (TTM)

276.63M

Total Cash (MRQ)

2.28B

Total Debt (MRQ)

58.58M

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Incyte (INCY) company profile

Incyte Corp. (NASDAQ: INCY) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics. The company’s lead drug, Jakafi, treats two types of rare blood cancer and graft. Its portfolio entails compounds in various stages, ranging from preclinical to late-stage development and commercialized products.

Latest INCY News

AD